Lupin reported INR22.98B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Bharat Petroleum INR 994.08B 122.84B Dec/2025
Cipla INR 26.32B 2.79B Mar/2026
Divis Laboratories Ltd INR 12.39B 1.76B Mar/2026
Dr.Reddys Laboratories INR 37.7B 1.54B Mar/2026
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
UPL INR 110.38B 43.65B Mar/2026